Therapeutic Focus
Capability by category
Organized in three tiers — documented Principal Investigator experience, broader clinical capability, and areas of future interest. Described at the phase and therapeutic level only.
Tier 1 Documented PI experience
Metabolic / Endocrine Active
GLP-1 / GIP therapy, type 2 diabetes, obesity, metabolic syndrome. Active Phase I metabolic program.
Respiratory Completed
COPD and chronic bronchitis. Completed Phase III trial.
Cardiovascular Active
Stroke, atrial fibrillation, and cardiometabolic risk.
Tier 2 Clinical capability areas
- Hypertension
- Hyperlipidemia / dyslipidemia
- Chronic kidney disease
- Congestive heart failure
- Hypothyroidism / endocrine
- Perimenopause / menopause & hormone optimization
Tier 3 Areas of interest / future focus
- Neurology — Alzheimer's / neurodegenerative
- Immunology & inflammation
- Mental health & behavioral disorders
- Oncology — novel modalities (ADCs, radiopharmaceuticals, cell/gene therapy)
Status reflects current accuracy. Active programs are marked active; completed trials are marked completed; interest areas are labeled as future focus and do not imply active enrollment. Protocol-level specifics are shared privately under a confidentiality agreement.
Aligned with your therapeutic program?
Let's discuss feasibility for your indication in Florida.